GB201106803D0 - Sonodynamic therapy - Google Patents

Sonodynamic therapy

Info

Publication number
GB201106803D0
GB201106803D0 GBGB1106803.8A GB201106803A GB201106803D0 GB 201106803 D0 GB201106803 D0 GB 201106803D0 GB 201106803 A GB201106803 A GB 201106803A GB 201106803 D0 GB201106803 D0 GB 201106803D0
Authority
GB
United Kingdom
Prior art keywords
sonodynamic therapy
sonodynamic
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1106803.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ulster University
Sonidel Ltd
Original Assignee
Ulster University
Sonidel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulster University, Sonidel Ltd filed Critical Ulster University
Priority to GBGB1106803.8A priority Critical patent/GB201106803D0/en
Publication of GB201106803D0 publication Critical patent/GB201106803D0/en
Priority to PCT/GB2012/050894 priority patent/WO2012143739A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
GBGB1106803.8A 2011-04-21 2011-04-21 Sonodynamic therapy Ceased GB201106803D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1106803.8A GB201106803D0 (en) 2011-04-21 2011-04-21 Sonodynamic therapy
PCT/GB2012/050894 WO2012143739A1 (en) 2011-04-21 2012-04-23 Sonodynamic therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1106803.8A GB201106803D0 (en) 2011-04-21 2011-04-21 Sonodynamic therapy

Publications (1)

Publication Number Publication Date
GB201106803D0 true GB201106803D0 (en) 2011-06-01

Family

ID=44147386

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1106803.8A Ceased GB201106803D0 (en) 2011-04-21 2011-04-21 Sonodynamic therapy

Country Status (2)

Country Link
GB (1) GB201106803D0 (en)
WO (1) WO2012143739A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130123781A1 (en) 2011-08-24 2013-05-16 California Institute Of Technology Targeting microbubbles
WO2014142927A1 (en) * 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
US9255907B2 (en) 2013-03-14 2016-02-09 Empire Technology Development Llc Identification of surgical smoke
KR20150010908A (en) * 2013-07-21 2015-01-29 더 스테이트 유니버시티 오브 뉴욕 버팔로 Contrast agent for combined photoacoustic and ultrasound imaging
US10646432B2 (en) 2015-06-18 2020-05-12 California Institute Of Technology Synthesis and application of microbubble-forming compounds
CN105233308B (en) * 2015-11-02 2018-10-30 中国科学院深圳先进技术研究院 A kind of acoustic contrast agent and the preparation method and application thereof for HIFU
GB201520649D0 (en) 2015-11-23 2016-01-06 Univ Ulster Sonodynamic therapy
GB201708663D0 (en) * 2017-05-31 2017-07-12 Univ Ulster Therapy
WO2019050963A1 (en) * 2017-09-05 2019-03-14 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Sonodynamic therapy using microbubbles and pulsed wave ultrasound methods and systems
CN108392641B (en) * 2018-04-03 2020-12-01 深圳大学 Nano emulsion and preparation method and application thereof
CN108853520B (en) * 2018-08-24 2021-04-13 重庆医科大学 Sound-sensitive lipid nanoparticle, application and preparation method thereof
CN109223800A (en) * 2018-10-26 2019-01-18 辽宁大学 Bis- para-totuidine base of 3,7--phenthazine -5- iodide and supersonic synergic are inhibiting the application in tumor cell proliferation
GB201819853D0 (en) 2018-12-05 2019-01-23 Innovation Ulster Ltd Therapy
GB201908352D0 (en) 2019-06-11 2019-07-24 Innovation Ulster Ltd Sonodynamic therapy
CN110585447B (en) * 2019-10-21 2021-11-16 广东医科大学 Preparation method and application of aggregated luminescent nano-particle material capable of being used as sound sensitizer
US10953023B1 (en) 2020-01-28 2021-03-23 Applaud Medical, Inc. Phospholipid compounds and formulations
CN111701030B (en) * 2020-07-22 2022-12-27 西南大学 Preparation method of active targeting zirconium dioxide nanoparticles with defect of acoustic power effect
US20220313820A1 (en) * 2020-08-27 2022-10-06 Sahmyook University Industry-Academic Cooperation Foundation Ultrasound-assisted drug delivery carrier using ultrasound contrast agent containing ligand conjugated with drug through ester bond
US11813330B2 (en) 2021-03-04 2023-11-14 Theralase Technologies, Inc. Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents
CN116236570A (en) * 2021-12-08 2023-06-09 深圳先进技术研究院 Development and application of living organism self-oxygen-generating sound sensitizer
CN116239153A (en) * 2022-12-15 2023-06-09 浙江大学杭州国际科创中心 FeMoO 4 Acid response sound power material and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
WO1999013943A1 (en) * 1996-03-05 1999-03-25 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
EP2480127A4 (en) * 2009-09-22 2015-06-24 Targeson Inc Optical imaging contrast agents and uses therof

Also Published As

Publication number Publication date
WO2012143739A1 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
GB201106803D0 (en) Sonodynamic therapy
ZA201305897B (en) Combination therapy
ZA201400120B (en) Combination therapy
PL2489413T3 (en) Therapy device
HK1197178A1 (en) Combination als therapy als
ZA201502595B (en) Therapeutic methods
PL2723330T3 (en) Vasoconstrictor-containing agent for combination therapy
EP2701744A4 (en) Combination therapy
IL231564A0 (en) Vaccine therapy
EP2687212A4 (en) Medicament
ZA201308117B (en) Avian-based treatment
GB201114226D0 (en) Combination therapy
GB201120096D0 (en) Novel therapy
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102265D0 (en) Treatment
GB201102275D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102273D0 (en) Treatment
GB201102272D0 (en) Treatment
GB201102271D0 (en) Treatment
GB201102276D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)